CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $5,081 (100.0% shares, 0.0% debt)

Holdings (12)

RZLT REZOLUTE INC 75.3%
Value ($000) $3,825 Shares 1,318,967 Est. Cost $9.52 Unrealized -54.3%
GLD SPDR GOLD TR 7.4%
Value ($000) $374 Shares 1,298 Est. Cost $246.72 Unrealized —
BRK/B BERKSHIRE HATHAWAY INC DEL 4.9%
Value ($000) $249 Shares 467 Est. Cost $360.98 Unrealized +34.7%
— MIND MEDICINE MINDMED INC 3.9%
Value ($000) $199 Shares 34,073 Est. Cost $8.91 Unrealized —
BCAX BICARA THERAPEUTICS INC 2.8%
Value ($000) $143 Shares 10,941 Est. Cost $25.50 Unrealized -47.9%
CMPX COMPASS THERAPEUTICS INC 1.6%
Value ($000) $83 Shares 43,465 Est. Cost $3.23 Unrealized -17.7%
LXEO LEXEO THERAPEUTICS INC 1.2%
Value ($000) $62 Shares 17,851 Est. Cost $13.31 Unrealized -66.7%
KYTX KYVERNA THERAPEUTICS INC 0.9%
Value ($000) $44 Shares 22,981 Est. Cost $23.94 Unrealized -87.7%
CRDF CARDIFF ONCOLOGY INC 0.8%
Value ($000) $42 Shares 13,287 Est. Cost $3.13 Unrealized +26.5%
IKT INHIBIKASE THERAPEUTICS INC 0.7%
Value ($000) $36 Shares 16,393 Est. Cost $2.49 Unrealized +0.7%
— ADICET BIO INC 0.3%
Value ($000) $13 Shares 17,488 Est. Cost $2.35 Unrealized —
CNTX CONTEXT THERAPEUTICS INC 0.2%
Value ($000) $11 Shares 18,403 Est. Cost $1.72 Unrealized -49.5%